Eswatini vs Namibia: Cause of death, by non-communicable diseases, ages 5-14, female
Eswatini
16.7%
in 2021
Namibia
17.0%
in 2021
Eswatini rank
170th
Namibia rank
167th
Cause of death, by non-communicable diseases, ages 5-14, female over time
- Eswatini
- Namibia
How they compare
Namibia currently reports 17.0% against 16.7% in Eswatini, a difference of 0.3%.
The two have swapped places 3 times across 6 shared years of data; in 2000 it was Eswatini ahead.
Eswatini ranks 170th and Namibia ranks 167th of 184 countries.
Across the 3 decades both report, Eswatini averaged higher in 2 and Namibia in 1.
Head to head by decade
| Decade | Eswatini | Namibia | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 5.3% | 4.9% | 0.4% | Eswatini |
| 2010s | 8.6% | 11.0% | 2.3% | Namibia |
| 2020s | 17.0% | 16.9% | 0.1% | Eswatini |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, ages 5-14, female, Eswatini or Namibia?
- Namibia, at 17.0% against 16.7% in Eswatini as of 2021.
- What is the difference in cause of death, by non-communicable diseases, ages 5-14, female between Eswatini and Namibia?
- 0.3%, with Namibia ahead.
- How many years of comparable data are there for Eswatini and Namibia?
- 6 years are reported by both, from 2000 to 2021.
- How do Eswatini and Namibia rank globally for cause of death, by non-communicable diseases, ages 5-14, female?
- Eswatini ranks 170th and Namibia ranks 167th of 184 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, ages 5-14, female (% of total female deaths ages 5-14). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of female deaths ages 5-14 due to non-communicable diseases divided by number of all female deaths ages 5-14, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.